Nakanishi Inc. (the “Company”) hereby announces the completion of its own share
repurchase pursuant to Article 156 of the Corporate Law applicable pursuant to Item
3, Article 165 of the same law, as well as the total number of shares of treasury stock
to be cancelled in accordance with Article 178 of the same law. These resolutions
were reached at the meeting of Board of Directors held on February 20, 2024. Details

Kanuma, Mar. 18, 2024

Contact
Investors
Daisuke Suzuki

are described below.

Corporate Vice President & Group CFO

Masatoshi Akiya
Head of Corporate CommunicationNobue Ebihara
Corporate Communication Specialist(1) Class of shares repurchased

Common stocks(2) Total number of shares repurchased

841,200 shares

Corporate Communication Specialist(3) Total amount of repurchase costs

JPY 1,999,766,300

ir@nsk-nakanishi.co.jp(4) Period of repurchase

From March 4, 2024 to March 15, 2024

Media

Saki Tabei

Yukino Kurosawa
Corporate Communication Specialist

Kazuki Takagi(1) Class of shares repurchased

Common stocks(2) Total number of shares repurchased

841,200 shares(3) Total amount of repurchase costs

JPY 1,999,766,300

Corporate Communication Specialist

pr@nsk-nakanishi.co.jp

About Nakanishi inc.
(1) Class of shares to be cancelled

Common stocks(2) Number of shares to be cancelled

841,200 shares(0.99% of total number of shares outstanding (excluding treasury shares))(3) Number of shares outstanding
after the cancellation

93,418,200 shares(4) Date of cancellation

April 5, 2024

Nakanishi raises as our mission thecreation of “brilliant progress” via
innovative “grinding technology”
through the lens of our corporate
philosophy “Our Core” values.
We aim to contribute to thedevelopment of medical care andthe realization of a better life for all
by creating new technology.
Based on “grinding technology”,
we have a differentiated productlineup under world-class brands in

1. Details of repurchase(1) Class of shares to be repurchased(2) Total number of shares to be repurchased

Common stocks
1,100,000 shares (Maximum)

the dental, surgical, and industrial
business fields, and are sold in 145
countries around the world.

(1.29% of total number of shares outstanding (excluding treasury shares))(3) Total amount of repurchase costs(4) Period of repurchase(5) Repurchase method

2. Details of cancellation(1) Class of shares to be cancelled(2) Number of shares to be cancelled(3) Cancellation date

Note:

JPY 2,000,000,000 (Maximum)
From February 26, 2024 to March 22, 2024
Open market purchase through the Tokyo Stock Exchange based on adiscretionary trading contract
Common stocks
All of the shares repurchased as described in (Reference) 1 above
April 5, 2024

This document is a translation of the original Japanese document and is only for reference purposes. All readers
are recommended to refer to the original version in Japanese of the release for complete information.

Source: Nakanishi Inc. www.nakanishi-inc.jp/ir/irnews

Nakanishi will continue to work
together with all employees of thegroup companies to create
innovative products that only we cancreate and contribute to the lives andhealth of people around the world.
The company’s shares are listed in
the Tokyo Stock Exchange.
Visit www.en.nakanishi-inc.jp for
more information about NakanishiInc. and our business.